Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kahr-and-cancer-focus-fund-announce-first-patient-dosed-in-phase-1b-clinical-trial-of-anti-cd47-product-candidate-dsp107-in-blood-cancers-301484721.html
https://www.prnewswire.com/news-releases/kahr-announces-46-5-million-financing-to-advance-its-multifunctional-immunotherapeutic-pipeline-301313437.html
https://www.fiercebiotech.com/biotech/kahr-reels-47m-to-fund-cd47-trial-work-tigit-prospect
https://endpts.com/an-israeli-biotech-is-looking-to-make-its-name-in-the-jampacked-cd47-space-is-bifunctionality-the-answer/